End-of-life care for COPD patients

Primary Care Respiratory Journal

Volumn 17, Issue 1, 2008, Pages 46-50

  Dean, Mervyn M ^a  

^a Western Memorial Regional Hospital Corner Brook   (Canada)

Author keywords

COPD; End of life care; Palliative care

Indexed keywords

OPIATE;

ARTICLE; CARE AND CARING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEATH; DISEASE COURSE; DYSPNEA; END OF LIFE CARE; GENERAL PRACTITIONER; HUMAN; PALLIATIVE THERAPY; PROGNOSIS; QUALITY OF LIFE; SURVIVAL;

ADVANCE CARE PLANNING; COMMUNICATION; DYSPNEA; HUMANS; PAIN; PALLIATIVE CARE; PHYSICIAN-PATIENT RELATIONS; PROFESSIONAL-FAMILY RELATIONS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; TERMINAL CARE;

EID: 40949150665     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2008.00007     Document Type: Article

References (40)

1. Neerkin J, Riley J. Ethical aspects of palliative care in lung cancer and end stage lung disease. Chron Respir Dis 2006;3:93-101.
2. Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care BMJ 2005;330:1007-11.
3. Elkington H, White P, Addington-Hall J, Higgs R, Edmonds P. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat Med 2005;19:485-91.
4. Murray SA, Pinnock H, Sheikh A. Palliative care for people with COPD: we need to meet the challenge. Prim Care Resp J 2006;15:362-4. doi:10.1016/j.pcrj.2006.08.008
5. O'Kelly N, Smith J. Palliative care for patients with end-stage COPD (letter). Prim Care Resp J 2007;16:57-8. doi:10.3132/pcrj.2007. 00003
6. Seamark DA, Seamark CJ, Halpin DMG. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. J Royal Soc Med 2007;100:225-33.
7. Goodridge D. People with chronic obstructive lung disease at the end of life: a review of the literature. International J Palliat Nursing 2006;12:390-6.
8. Coventry PA, Grande GE, Richards DA, Todd CJ. Prediction of appropriate timing of palliative care for older adults with a non-malignant life-threatening disease: a systematic review. Age Ageing 2005;34:218-27.
9. Lynn J, Schall MW, Milne C, Nolan KM, Kabcenell A. Quality improvements in end of life care: insights from two collaboratives. Jt Comm J Qual Improv 2000:26(5):254-67.
10. Steinhauser KE, Clipp EC, McNeilly M, et al. In search of a good death; observations of patients, families and providers. Ann Intern Med 2000;132:825-32.
11. Heyland DK, Dodek P, Rocker G, et al. What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ 2006;174(5):627-33.
12. Varkey B. Unfulfilled palliative care needs of chronic obstructive pulmonary disease patients. Curt Opin Pulm Med 2006;12:103-05.
13. Pang SMC, Chan K-S, Chung BPM, et al. Assessing quality of life of patients with advanced chronic obstructive pulmonary disease in the end of life. J Palliat Care 2005;21:180-7.
14. Curtis JR, Wenrich MD, Carline JD, Shannon SE, Ambrozy DM, Ramsey PG. Patients' perspectives on physician skill in end-of-life care. Difference between patients with COPD, cancer, and AIDS. Chest 2002;122:356- 62.
15. National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care, executive summary. J Palliat Med 2004;7:611-27.
16. Knauft E, Nielsen EL, Engelberg RA, Patrick D, Curtis JR. Barriers and facilitators to end-of-life care communication for patients with COPD. Chest 2005;127:2188-96.
17. Robinson T. Living with severe hypoxic COPD: the patients' experience. Nurs Times 2005;101:38-42.
18. Kirk P, Kirk I, Kristjanson LJ. What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study BMJ 2004;328:1343. doi:10.1136/bmj.38103.423576. 55
19. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end-stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000;55:1000-06.
20. Sahm S, Will R, Hommel G. What are cancer patients' preferences about treatment at the end of life, and who should start talking about it? A comparison with healthy people and medical staff. Support Care Cancer 2005;13:206-14.
21. Lamont EB, Siegler M. Paradoxes in cancer patients' advance care planning Palliat Med 2000;3:27-35.
22. Cartwright CM, Parker MH. Advance care planning and end of life decision making. Aust Fam Physician 2004;33:815-19.
23. Allen R, Ventura N. Advance directives use in acute care hospitals health law Ethics Regul 2005;7:86-91.
24. Bruera ref Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage 1990;5:341-4.
25. Westphal CG, Campbell ML. Nebulized morphine for terminal dyspnea. Am J Nurs 2002;Suppl:11-15.
26. Jankelson D, Hosseini K, Mather LE, Seale JP, Young IH. Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease. Eur Respir J 1997;10:2270-4.
27. Bauford W, Saylor TT, Stansbury DW, Avalos K, Light RW. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. Chest 1993;104:175-8,
28. Foral PA, Malesker MA, Huerta G, Hilleman DE. Nebulized opioids use in COPD. Chest 2004;125:691-4.
29. Brown SJ, Eichner SF, Jones JR. Nebulized morphine for relief of dyspnea due to chronic lung disease. Ann Pharmacother 2005;39:1088-92.
30. Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage 2006;31:38-47.
31. Twycross R, Wilcock A, eds. Central Nervous System. In: Hospice and Palliative Care Formulary USA palliativedrugs.com Ltd. 2006:92
32. Scott RC, Besag FM, Boyd SG, Berry D, Neville BG. Buccal absorption of midazolam:pharmacokinetics and EEG pharmacodynamics. Epilepsia 1998;39(3):290-4.
33. Lim TW, Thomas E, Choo SM. Premedication with midazolam is more effective by the buccal than oral route. Can J Anaesthesia 1997;44(7):723- 6.
34. Borner K, Lode H, Hampel B, Pfeuffer M, Koeppe P. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration. Chemotherapy 1985;31:237-45.
35. Udezue E. Lidocaine inhalation for cough suppression. Am J Emerg Med 2001;19:206-07.
36. McAlpine LG. Thomson NC. Lidocaine-induced bronchoconstriction in asthmatic patients. Relation to histamine airway responsiveness and effect of preservative. Chest 1989;96:1012-15.
37. Moroni M, Porta C, Gualtieri G, Nastasi G, Tinelli C. Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients. Brit J Cancer 1996;74:309-11.
38. Hugel H, Ellershaw J, Gambles M. Respiratory tract secretions in the dying patient: a comparison between glycopyrronium and hysocine hydrobromide. J Palliat Med 2006;9:279-84.
39. Bennet M, Lucas V, Hughes A, O'Donnel V, Wee B. Using anti-muscarinic drugs in the management of death rattle:evidence-based guidelines for palliative care. Palliative Medicine 2002;16:369-74.
40. De Graeff A, Dean M. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards. J Palliat Med 2007;10:67-85.